Skip to main content
  • Poster presentation
  • Open access
  • Published:

Right ventricular size assessed by cardiovascular MRI may predict mortality after left ventricular assist device placement


Early right ventricular (RV) failure after insertion of an implantable left ventricular assist device (LVAD) is associated with a poor prognosis and increased mortality. Improved assessment of RV volumes with cardiovascular magnetic resonance imaging (CMR) prior to LVAD placement may lead to more optimal patient selection.


Patients were referred for cardiovascular magnetic resonance imaging prior to LVAD placement. We assessed the association of mortality to pre-LVAD right ventricular end systolic volume index (RVESVI), right ventricular end diastolic volume index (RVEDVI), left ventricular ejection fraction (LVEF) by CMR. Right ventricular stroke work index (RVSWI) was determined by pre-LVAD right heart catheterization.


We studied 15 consecutive patients (mean age, 54 ±12 years; 54% male) who received HVAD (60%) and HeartMate II (40%) LVADs for a diagnosis of dilated cardiomyopathy (57%) and ischemic cardiomyopathy (43%). 26.7% of patients had an implantable defibrillator (ICD) at the time of the MRI (figure 1), without any device-related complications or issues with image quality. A total of 3 deaths occurred during a median follow-up of 19 months (range, 3 to 31 months). By univariate analysis (table 1), mortality was significantly associated with increased RVESVI (116.9 ml ± 32.8 vs. 65.1 ml ± 25.6; p = 0.01) and RVEDVI (140.4 ml ± 21 vs. 86.6 ml ± 19.1; p = 0.001) when assessed prior to implantation of LVAD by CMR. There was no observed association in mortality with the more typical risk predictors of LVEF or RVSWI assessed prior to LVAD placement.

Figure 1
figure 1

4-chamber (left) and short-axis (right) turbo-GRE images of right ventricle in pre-LVAD patient with ICD. Arrows indicate minimal ICD lead artifact.

Table 1 Cardiovasuclar Magnetic Resonance imaging measurement of study population.


Increased RVESVI and RVEDVI assessed by CMR prior to implantation of LVADs is a predictor of post-implant mortality, while more typical measures such as LVEF was not. CMR acquisition and RV image quality was not hindered by implantable cardiac devices. Evaluation of RV volumes by CMR may improve risk-stratification and further refine patient selection for LVAD implantation.



Author information

Authors and Affiliations


Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit

The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Timmons, M., Welsh, A.C., Baruah, D. et al. Right ventricular size assessed by cardiovascular MRI may predict mortality after left ventricular assist device placement. J Cardiovasc Magn Reson 17 (Suppl 1), P181 (2015).

Download citation

  • Published:

  • DOI: